Results 161 to 170 of about 12,264,579 (389)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme +8 morewiley +1 more sourceAdenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski +14 morewiley +1 more sourceGut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy
Molecular Oncology, EarlyView.In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte +7 morewiley +1 more sourceGuidelines for the use and interpretation of assays for monitoring autophagy
, 2012 D. Klionsky, Fábio Camargo Abdalla, H. Abeliovich, Robert T. Abraham, Abraham Acevedo-Arozena, K. Adeli, Lotta Agholme, M. Agnello, P. Agostinis, J. Aguirre-Ghiso, Hyung Jun Ahn, Ouardia Ait-Mohamed, Slimane Ait-Si-Ali, T. Akematsu, Shizou Akira, H. Al-Younes, Munir A. Al‐Zeer, Matthew Albert, R. L. Albin, J. Alegre-Abarrategui, M. F. Aleo, M. Alirezaei, Alexandru Almasan, M. Almonte-Becerril, Atsuo Amano, Ravi K. Amaravadi, Shoba Amarnath, Amal O. Amer, Nathalie Andrieu-Abadie, V. Anantharaman, David K. Ann, S. Anoopkumar‐Dukie, Hiroshi Aoki, N. Apostolova, Giuseppe Arancia, John P. Aris, K. Asanuma, N. Asare, Hisashi Ashida, V. Askanas, David S. Askew, P. Auberger, M. Baba, Steven K. Backues, E. Baehrecke, Ben A. Bahr, Xue-Yuan Bai, Yannick Bailly, R. Baiocchi, G. Baldini, W. Balduini, Andrea Ballabio, B. Bamber, Edward T. W. Bampton, G. Bánhegyi, Clinton R. Bartholomew, D. Bassham, Robert C. Bast, H. Batoko, Boon-Huat Bay, Isabelle Beau, Daniel M. Béchet, Thomas J. Begley, Christian Behl, Christian Behrends, Soumeya Bekri, Bryan Bellaire, L. Bendall, Luca Benetti, L. Berliocchi, Henri Bernardi, F. Bernassola, Sébastien Besteiro, I. Kiššová, Xiaoning Bi, M. Biard-Piechaczyk, Janice S. Blum, L. Boise, P. Bonaldo, David L. Boone, B. Bornhauser, K. Bortoluci, Ioannis Bossis, F. Bost, Jean-Pierre Bourquin, Patricia Boya, Michaël Boyer-Guittaut, P. Bozhkov, N. R. Brady, Claudio Brancolini, A. Brech, J. Brenman, A. Brennand, E. Bresnick, P. Brest, Dave Bridges, Molly L Bristol, Paul S. Brookes, Eric J. Brown, J. Brumell, N. Brunetti‐Pierri, Ulf T. Brunk, Dennis E. Bulman, S. Bultman, G. Bultynck, Lena F. Burbulla, Wilfried Bursch, Jonathan P Butchar, W. Buzgariu, S. Bydlowski, Ken Cadwell, M. Cahova, Dongsheng Cai, Jiyang Cai, Qian Cai, Bruno Calabretta, Javier Calvo-Garrido, N. Camougrand, M. Campanella, J. Campos-Salinas, E. Candi, Lizhi Cao, Allan Caplan, S. Carding, Sandra M. Cardoso, J. Carew, Cathleen R Carlin, V. Carmignac, Letícia de Am Carneiro, Serena Carra, R. Caruso, G. Casari, Caty Casas, R. Castino, E. Cebollero, Francesco Cecconi, J. Celli, Hassan Chaachouay, H. Chae, C.‐Y. Chai, David C. Chan, Edmond Y W Chan, Raymond Chuen-Chung Chang, Chi-Ming Che, Ching-Chow Chen, Guang-Chao Chen, Guo-Qiang Chen, Min Chen, Quanliang Chen, Steve S.-L. Chen, Wen li Chen, Xi Chen, Xiangmei Chen, Xiequn Chen, Ye-Guang Chen, Yingyu Chen, Yongqiang Chen, Yu-Jen Chen, Zhixiang Chen, Alan Cheng, Christopher H. K. Cheng, Yan Cheng, Heesun Cheong, Jae Ho Cheong, Sara Cherry, R. Chess-Williams, Z. H. Cheung, É. Chevet, Hui-Ling Chiang, R. Chiarelli, Tomoki Chiba, L. Chin, Shih‐Hwa Chiou, F. Chisari, C. H. Cho, Dong-Hyung Cho, Augustine M. K. Choi, Doo Seok Choi, Kyeong Beom Choi, Mary E. Choi, Salem Chouaib, D. Choubey, V. Choubey, Charleen T. Chu, Tsung-Hsien Chuang, S. Chueh, Taehoon Chun, Y. Chwae, M. Chye, R. Ciarcia, M. Ciriolo, Michael J. Clague, Robert S. B. Clark, P.G.H. Clarke, Robert Clarke, Patrice Codogno, H. Coller, María I Colombo, S. Comincini, M. Condello, F. Condorelli, Mark R. Cookson, Graham H. Coombs, Isabelle Coppens, Ramón Corbalán, Pascale Cossart, P. Costelli, S. Costes, Ana Coto-Montes, E. Couve, F. Coxon, J. Cregg, José L. Crespo, Marianne J. Cronjé, Ana Maria Cuervo, Joseph J. Cullen, M. Czaja, M. D’Amelio, A. Darfeuille-Michaud, Lester M. Davids, Faith E. Davies, M. Felici, J. D. Groot, C. D. Haan, L. Martino, A. Milito, V. Tata, Jayanta Debnath, A. Degterev, Benjamin Dehay, L. Delbridge, F. Demarchi, Yi Deng, Jörn Dengjel, Paul Dent, Donna Denton, V. Deretic, Shyamal D. Desai, R. Devenish, M. Gioacchino, G. D. Paolo, C. D. Pietro, Guillermo Díaz-Araya, I. Díaz-Laviada, Maria T. Diaz-Meco, J. Díaz-Nido, I. Dikič, S. P. Dinesh-Kumar, Wen-Xing Ding, C. Distelhorst, A. Diwan, M. Djavaheri-Mergny, S. Dokudovskaya, Zheng Dong, F. C. Dorsey, V. E. Dosenko, James J. Dowling, Stephen J. Doxsey, Marlène Dreux, Mark E. Drew, Qiuhong Duan, M. Duchosal, Karen Duff, Isabelle Dugail, Madeleine Durbeej, M. Duszenko, Charles L. Edelstein, Aimee L. Edinger, Gustavo Egea, Ludwig Eichinger, N Tony Eissa, S. Ekmekcioglu, W. El-Deiry, Z. Elazar, M. Elgendy, L. Ellerby, K. Eng, Anna-Mart Engelbrecht, S. Engelender, J. Erenpreisa, Ricardo Escalante, A. Esclatine, E. Eskelinen, L. Espert, V. Espina, Huizhou Fan, Jia Fan, Qianyu Fan, Zhen Fan, Shengyun Fang, Yongqi Fang, M. Fanto, A. Fanzani, T. Farkas, Jean-Claude Farré, Mathias Faure, M. Fechheimer, Carl G. Feng, Jian Feng, Qili Feng, Youji Feng, László Fésüs, R. Feuer, M. Figueiredo-Pereira, G. Fimia, D. Fingar, Steven Finkbeiner, Toren Finkel, Kim D. Finley, M. Florez-McClure, Salvatore Florio, E. Fon, Francesco Fornai, Franco Fortunato, R. Fotedar, Daniel H. Fowler, Howard Fox, Rodrigo Franco, Lisa B. Frankel, Marc Fransen, José M. Fuentes, J. Fueyo, Jun Fujii, Kozo Fujisaki, E. Fujita, Mitsunori Fukuda, R. Furukawa, Matthias Gaestel, Philippe Gailly, Małgorzata Gajewska, Brigitte Galliot, Vincent Galy, Subramaniam Ganesh, Barry Ganetzky, I. Ganley, F. Gao, George F. Gao, Jinming Gao, Lorena García, G. Garcia-Manero, M. Garcia-Marcos, Marjan Garmyn, A. Gartel, E. Gatti, Mathias Gautel, Thomas R. Gawriluk, Matthew E Gegg, Jiefei Geng, Marc Germain, J. Gestwicki, D. Gewirtz, Saeid Ghavami, Pradipta Ghosh, A. M. Giammarioli, A. Giatromanolaki, Spencer B Gibson, R. Gilkerson, M. Ginger, Henry N. Ginsberg, J. Gołąb, M. Goligorsky, P. Golstein, C. Gomez-Manzano, E. Goncu, Céline Gongora, Claudio González, Ramon Gonzalez, Cristina González-Estévez, R. González-Polo, E. González-Rey, Nikolai V. Gorbunov, S. Gorski, S. Goruppi, Roberta A. Gottlieb, D. Gozuacik, G. Granato, G. Grant, Kim N. Green, A. Gregorc, F. Gros, Charles Grose, T. W. Grunt, Philippe Gual, Jun-Lin Guan, Kun-Liang Guan, Sylvie Guichard, A. Gukovskaya, I. Gukovsky, J. Gunst, Åsa B. Gustafsson, A. Halayko, Amber Hale, S. Halonen, Maho Hamasaki, Feng Han, Ting Han, Michael K. Hancock, M. Hansen, Hisashi Harada, Masaru Harada, S. Hardt, J. Harper, Adrian L. Harris, James S. Harris, Steven D. Harris, M. Hashimoto, Jeffrey A. Haspel, Shinichiro Hayashi, L. Hazelhurst, Congcong He, You-Wen He, Marie-Josée Hébert, Kim A. Heidenreich, M. Helfrich, G. Helgason, E. Henske, Brian Herman, Paul K. Herman, Claudio Hetz, Sabine Hilfiker, Joseph A. Hill, Lynne J. Hocking, Paul Hofman, Thomas G. Hofmann, J. Höhfeld, T. Holyoake, Ming-Huang Hong, David A. Hood, G. Hotamisligil, E. Houwerzijl, M. Høyer-Hansen, Bingren Hu, Chien-An Hu, Hong-Ming Hu, Y. Hua, Canhua Huang, Ju Huang, Shengbing Huang, Wei‐Pang Huang, Tobias B. Huber, Won-Ki Huh, T. Hung, Tedd R Hupp, Gangmin Hur, James B. Hurley, Sabah N. A. Hussain, P. Hussey, Jung Jin Hwang, S. Hwang, Atsuhiro Ichihara, Shirin Ilkhanizadeh, K. Inoki, T. Into, V. Iovane, Juan L. Iovanna, Nancy Y. Ip, Y. Isaka, H. Ishida, C. Isidoro, Ken-ichi Isobe, Akiko Iwasaki, Marta Izquierdo, Y. Izumi, Panu Jaakkola, M. Jäättelä, George R. Jackson, William T. Jackson, B. Janji, M. Jendrach, Ju Hong Jeon, E. Jeung, Hongchi Jiang, Hongchi Jiang, Jean X. Jiang, Ming Jiang, Qing Jiang, Xuejun Jiang, Alberto Jiménez, Meiyan Jin, Shengkan Jin, Cheol O. Joe, T. Johansen, Daniel E. Johnson, Gail V. W. Johnson, Nicola L. Jones, Bertrand Joseph, Suresh K. Joseph, Annie M. Joubert, Gábor Juhász, L. Juillerat-Jeanneret, Chang Jung, Yong-Keun Jung, Kai Kaarniranta, Allen Kaasik, Tomohiro Kabuta, M. Kadowaki, Katarina Kågedal, Y. Kamada, Vitaliy O. Kaminskyy, H. Kampinga +499 moresemanticscholar +1 more sourceA bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer
Molecular Oncology, EarlyView.Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo +15 morewiley +1 more sourceIn vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma
Molecular Oncology, EarlyView.Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni +14 morewiley +1 more source
